[New clinical application of spironolactone].
D000311:Adrenal Glands / Q000187:drug effects; D000328:Adult; D000959:Antihypertensive Agents; D001201:Ascites / Q000188:drug therapy; D001929:Brain Edema / Q000188:drug therapy; D004232:Diuretics; D004487:Edema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D007686:Kidney Tubules, Distal / Q000187:drug effects; D007687:Kidney Tubules, Proximal / Q000187:drug effects; D010245:Paralyses, Familial Periodic / Q000188:drug therapy; D011245:Pregnadienes / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D011245:Pregnadienes; D013148:Spironolactone; D014223:Triamterene